Bladder cancer is the 6th most common cancer in the US, yet significant disparities in access to guideline-concordant care persist—particularly among Black patients, women, older adults, uninsured individuals, and those in rural communities. For many patients with bladder cancer, access to personalized, high-quality care remains limited due to systemic inequities that impact timely diagnosis, treatment access, and use of supportive services. Overcoming these disparities requires data-driven strategies and a reimagining of care delivery grounded in equity.
ACCC provides resources to support cancer care professionals in identifying and addressing barriers to guideline-concordant care, helping ensure all patients receive equitable, evidence-based treatment.
Navigate the growing complexity of bladder cancer care using a framework for best practices developed by ACCC and the Bladder Cancer Advocacy Network (BCAN). Qualifying cancer programs/practices may join a public registry on BCAN.org.
Download Now
